;; Comprehensive Hedge Fund Onboarding Workflow
;; Complete demonstration of multi-domain DSL integration for institutional client onboarding
;;
;; Scenario: Quantum Capital Management (Luxembourg UCITS fund) onboarding for
;; prime brokerage services including custody, derivative trading, and financing
;;
;; Client Profile:
;; - Luxembourg SICAV fund (€2.5B AUM)
;; - Complex multi-jurisdiction structure
;; - Sophisticated derivative strategies
;; - Institutional investor base
;;
;; Domains Integrated: Document, KYC, UBO, Compliance, ISDA, Onboarding
;; Regulatory Frameworks: CSSF, ESMA, EMIR, MiFID II, AIFMD

;; ============================================================================
;; PHASE 1: INITIAL DOCUMENT COLLECTION & CATALOGING
;; ============================================================================

;; Fund's Articles of Incorporation (Luxembourg)
(document.catalog
  :document-id "doc-quantum-incorporation-001"
  :document-type "ARTICLES_OF_INCORPORATION"
  :issuer "luxembourg_rcs"
  :title "Articles of Incorporation - Quantum Capital SICAV"
  :parties ["fund-quantum-capital-sicav"]
  :document-date "2021-03-22"
  :jurisdiction "LU"
  :language "EN"
  :confidentiality-level "RESTRICTED"
  :extracted-data {
    :fund.legal_name "Quantum Capital SICAV"
    :fund.registration_number "B-203456"
    :fund.jurisdiction "LU"
    :fund.fund_type "UCITS_SICAV"
    :fund.incorporation_date "2021-03-22"
    :fund.share_capital 31000
    :fund.currency "EUR"
    :fund.registered_office "15 Avenue de la Liberté, L-1931 Luxembourg"
    :fund.business_purpose "Collective investment in transferable securities"
  })

;; CSSF Authorization Letter
(document.catalog
  :document-id "doc-quantum-cssf-auth-001"
  :document-type "REGULATORY_AUTHORIZATION"
  :issuer "cssf_luxembourg"
  :title "UCITS Authorization - Quantum Capital SICAV"
  :parties ["fund-quantum-capital-sicav"]
  :document-date "2021-04-15"
  :jurisdiction "LU"
  :confidentiality-level "RESTRICTED"
  :extracted-data {
    :regulatory.authority "CSSF"
    :regulatory.license_type "UCITS_V"
    :regulatory.license_number "S00234567"
    :regulatory.authorization_date "2021-04-15"
    :regulatory.status "ACTIVE"
    :regulatory.eligible_assets ["equities" "bonds" "derivatives" "money_market"]
    :regulatory.investment_restrictions "UCITS_COMPLIANT"
    :regulatory.maximum_leverage 200
  })

;; Management Company Agreement
(document.catalog
  :document-id "doc-quantum-mgmt-agreement-001"
  :document-type "MANAGEMENT_AGREEMENT"
  :issuer "quantum_asset_mgmt_sa"
  :title "Management Company Agreement - Quantum Asset Management"
  :parties ["fund-quantum-capital-sicav" "quantum-asset-mgmt-sa"]
  :document-date "2021-03-22"
  :confidentiality-level "RESTRICTED"
  :extracted-data {
    :mgmt.company_name "Quantum Asset Management SA"
    :mgmt.company_registration "B-198765"
    :mgmt.management_fee 1.50
    :mgmt.performance_fee 20.0
    :mgmt.high_water_mark true
    :mgmt.agreement_term "INDEFINITE"
    :mgmt.termination_notice 90
  })

;; Latest Audited Financial Statements
(document.catalog
  :document-id "doc-quantum-financials-2023"
  :document-type "AUDITED_FINANCIAL_STATEMENTS"
  :issuer "pwc_luxembourg"
  :title "Audited Annual Report - Quantum Capital SICAV (2023)"
  :parties ["fund-quantum-capital-sicav"]
  :document-date "2024-03-31"
  :confidentiality-level "CONFIDENTIAL"
  :extracted-data {
    :financials.total_net_assets 2500000000
    :financials.management_fee 37500000
    :financials.performance_fee 45000000
    :financials.total_return 18.5
    :financials.sharpe_ratio 1.42
    :financials.maximum_drawdown -8.3
    :financials.currency "EUR"
    :financials.fiscal_year_end "2023-12-31"
    :financials.auditor "PwC Luxembourg"
  })

;; Prospectus and Key Investor Information
(document.catalog
  :document-id "doc-quantum-prospectus-001"
  :document-type "FUND_PROSPECTUS"
  :issuer "quantum_asset_mgmt_sa"
  :title "Prospectus - Quantum Capital SICAV"
  :parties ["fund-quantum-capital-sicav"]
  :document-date "2024-01-15"
  :jurisdiction "LU"
  :confidentiality-level "PUBLIC"
  :extracted-data {
    :investment.strategy "GLOBAL_EQUITY_LONG_SHORT"
    :investment.geographic_focus "GLOBAL"
    :investment.sector_focus "TECHNOLOGY_HEALTHCARE"
    :investment.leverage_range [100, 200]
    :investment.derivative_usage "HEDGING_SPECULATION"
    :investment.minimum_investment 100000
    :risk.risk_rating 5
    :risk.target_volatility 15.0
    :risk.var_99_daily 2.5
  })

;; Verify regulatory authorization
(document.verify
  :document-id "doc-quantum-cssf-auth-001"
  :verification-method "REGULATORY_API"
  :verifier "cssf_verification_service"
  :verification-date "2024-11-10"
  :verification-result "AUTHENTIC"
  :verification-details {
    :api-endpoint "https://cssf.lu/en/supervision/investment-funds/"
    :license-status "ACTIVE"
    :last-compliance-review "2024-09-30"
    :regulatory-standing "GOOD"
    :no-sanctions true
  })

;; AI-powered financial analysis
(document.extract
  :document-id "doc-quantum-financials-2023"
  :extraction-method "AI_FINANCIAL_ANALYSIS"
  :extracted-date "2024-11-10"
  :extractor "GEMINI_FUND_ANALYZER"
  :extracted-attributes {
    :risk.information_ratio 0.95
    :risk.tracking_error 12.8
    :risk.beta_to_market 0.75
    :risk.correlation_to_market 0.68
    :performance.alpha 8.2
    :performance.sortino_ratio 2.1
    :liquidity.avg_daily_volume 15000000
    :liquidity.redemption_frequency "DAILY"
    :concentration.top_10_holdings 35.0
  }
  :confidence-score 0.97)

;; ============================================================================
;; PHASE 2: ENTITY MODELING & CORPORATE STRUCTURE
;; ============================================================================

;; Define comprehensive KYC investigation
(define-kyc-investigation
  :id "quantum-capital-kyc-investigation"
  :target-entity "fund-quantum-capital-sicav"
  :jurisdiction "LU"
  :kyc-level "INSTITUTIONAL_ENHANCED"
  :regulatory-framework "CSSF_CDD"
  :investigation-date "2024-11-10"
  :investigator "kyc-team-luxembourg"
  :complexity-level "HIGH"
  :expected-duration 14)

;; Create main fund entity
(entity
  :id "fund-quantum-capital-sicav"
  :label "Fund"
  :props {
    :legal-name "Quantum Capital SICAV"
    :registration-number "B-203456"
    :jurisdiction "LU"
    :entity-type "UCITS_SICAV"
    :regulatory-status "CSSF_AUTHORIZED"
    :business-activity "Collective Investment Scheme"
    :aum 2500000000
    :currency "EUR"
    :inception-date "2021-04-15"
    :domicile "Luxembourg"
    :investment-manager "quantum-asset-mgmt-sa"
    :custodian "state-street-lux"
    :administrator "rbc-investor-services-lux"
  }
  :document-evidence ["doc-quantum-incorporation-001" "doc-quantum-cssf-auth-001"])

;; Management company entity
(entity
  :id "quantum-asset-mgmt-sa"
  :label "Company"
  :props {
    :legal-name "Quantum Asset Management SA"
    :registration-number "B-198765"
    :jurisdiction "LU"
    :entity-type "MANAGEMENT_COMPANY"
    :regulatory-status "CSSF_AUTHORIZED"
    :business-activity "Fund Management"
    :aum-managed 4200000000
    :license-type "AIFM_UCITS"
    :established-date "2018-06-15"
  }
  :document-evidence ["doc-mgmt-company-auth-001"])

;; Key management personnel
(entity
  :id "person-dr-elena-kowalski"
  :label "Person"
  :props {
    :full-name "Dr. Elena Kowalski"
    :nationality "DE"
    :date-of-birth "1975-09-12"
    :position "Chief Investment Officer"
    :years-experience 18
    :qualifications ["CFA" "FRM" "PhD_Finance"]
    :regulatory-approvals ["CSSF_APPROVED_PERSON"]
    :pep-status false
    :sanctions-status "CLEAR"
  }
  :document-evidence ["doc-elena-cv-001" "doc-elena-regulatory-approval-001"])

(entity
  :id "person-michael-brennan"
  :label "Person"
  :props {
    :full-name "Michael Brennan"
    :nationality "IE"
    :date-of-birth "1968-02-28"
    :position "Chief Executive Officer"
    :years-experience 25
    :qualifications ["CFA" "MBA_Wharton"]
    :regulatory-approvals ["CSSF_APPROVED_PERSON" "PCI_APPROVED"]
    :pep-status false
    :sanctions-status "CLEAR"
  }
  :document-evidence ["doc-michael-cv-001" "doc-michael-regulatory-approval-001"])

;; Institutional shareholders/investors
(entity
  :id "pension-fund-abp-nl"
  :label "Fund"
  :props {
    :legal-name "Stichting Pensioenfonds ABP"
    :registration-number "41220175"
    :jurisdiction "NL"
    :entity-type "PENSION_FUND"
    :aum 528000000000
    :regulatory-status "DNB_SUPERVISED"
    :investment-quantum 250000000
    :investment-date "2022-08-15"
  })

(entity
  :id "sovereign-wealth-fund-sg"
  :label "Fund"
  :props {
    :legal-name "GIC Private Limited"
    :registration-number "198700784M"
    :jurisdiction "SG"
    :entity-type "SOVEREIGN_WEALTH_FUND"
    :regulatory-status "MAS_EXEMPTED"
    :investment-quantum 500000000
    :investment-date "2023-03-10"
  })

;; ============================================================================
;; PHASE 3: OWNERSHIP & CONTROL RELATIONSHIPS
;; ============================================================================

;; Management company relationship
(edge
  :from "quantum-asset-mgmt-sa"
  :to "fund-quantum-capital-sicav"
  :type "MANAGES"
  :props {
    :relationship-type "MANAGEMENT_AGREEMENT"
    :management-fee 1.50
    :performance-fee 20.0
    :control-level "OPERATIONAL"
    :agreement-date "2021-03-22"
  }
  :evidence ["doc-quantum-mgmt-agreement-001"])

;; Key person control relationships
(edge
  :from "person-dr-elena-kowalski"
  :to "quantum-asset-mgmt-sa"
  :type "HAS_CONTROL"
  :props {
    :control-type "CHIEF_INVESTMENT_OFFICER"
    :control-mechanism "PORTFOLIO_MANAGEMENT"
    :control-strength "HIGH"
    :appointment-date "2021-04-01"
    :voting-rights 0.0
    :economic-interest 0.0
  }
  :evidence ["doc-appointment-letter-elena-001"])

(edge
  :from "person-michael-brennan"
  :to "quantum-asset-mgmt-sa"
  :type "HAS_CONTROL"
  :props {
    :control-type "CHIEF_EXECUTIVE_OFFICER"
    :control-mechanism "EXECUTIVE_MANAGEMENT"
    :control-strength "HIGH"
    :appointment-date "2018-06-15"
    :voting-rights 0.0
    :economic-interest 0.0
  }
  :evidence ["doc-appointment-letter-michael-001"])

;; Major investor relationships
(edge
  :from "pension-fund-abp-nl"
  :to "fund-quantum-capital-sicav"
  :type "HAS_INVESTMENT"
  :props {
    :investment-amount 250000000
    :investment-percentage 10.0
    :investment-type "INSTITUTIONAL_SHARES"
    :share-class "I_EUR"
    :subscription-date "2022-08-15"
    :lock-up-period 0
  }
  :evidence ["doc-subscription-agreement-abp-001"])

(edge
  :from "sovereign-wealth-fund-sg"
  :to "fund-quantum-capital-sicav"
  :type "HAS_INVESTMENT"
  :props {
    :investment-amount 500000000
    :investment-percentage 20.0
    :investment-type "INSTITUTIONAL_SHARES"
    :share-class "I_EUR"
    :subscription-date "2023-03-10"
    :lock-up-period 12
  }
  :evidence ["doc-subscription-agreement-gic-001"])

;; ============================================================================
;; PHASE 4: ENHANCED KYC VERIFICATION
;; ============================================================================

;; Comprehensive fund verification
(kyc.verify
  :entity-id "fund-quantum-capital-sicav"
  :verification-type "INSTITUTIONAL_FUND"
  :method "ENHANCED_DUE_DILIGENCE"
  :verified-at "2024-11-10T10:00:00Z"
  :verification-outcome "APPROVED"
  :risk-rating "MEDIUM_HIGH"
  :verification-details {
    :regulatory-authorization true
    :fund-classification "UCITS_V"
    :investment-strategy "SOPHISTICATED"
    :geographic-exposure "GLOBAL"
    :derivative-usage "EXTENSIVE"
    :leverage-monitoring true
    :liquidity-assessment "ADEQUATE"
    :operational-controls "ROBUST"
  })

;; Management company verification
(kyc.verify
  :entity-id "quantum-asset-mgmt-sa"
  :verification-type "MANAGEMENT_COMPANY"
  :method "ENHANCED_DUE_DILIGENCE"
  :verified-at "2024-11-10T11:00:00Z"
  :verification-outcome "APPROVED"
  :risk-rating "MEDIUM"
  :verification-details {
    :regulatory-status "CSSF_AUTHORIZED"
    :track-record "ESTABLISHED"
    :aum-stability "GROWING"
    :personnel-qualifications "HIGH"
    :compliance-framework "COMPREHENSIVE"
  })

;; Key person verification
(kyc.verify
  :entity-id "person-dr-elena-kowalski"
  :verification-type "KEY_PERSON"
  :method "ENHANCED_DUE_DILIGENCE"
  :verified-at "2024-11-10T12:00:00Z"
  :verification-outcome "APPROVED"
  :risk-rating "LOW"
  :verification-details {
    :regulatory-approval true
    :professional-qualifications "EXTENSIVE"
    :track-record "STRONG"
    :reputation-check "POSITIVE"
    :sanctions-screening "CLEAR"
    :adverse-media "NONE"
  })

;; ============================================================================
;; PHASE 5: MULTI-JURISDICTION COMPLIANCE
;; ============================================================================

;; EU regulatory compliance (MiFID II)
(compliance.verify
  :entity-id "fund-quantum-capital-sicav"
  :framework "MIFID_II"
  :check-type "PROFESSIONAL_CLIENT"
  :verified-at "2024-11-10T13:00:00Z"
  :compliance-outcome "COMPLIANT"
  :classification "PROFESSIONAL_CLIENT"
  :requirements-met ["QUANTITATIVE_TEST" "QUALITATIVE_TEST" "PROCEDURE_TEST"])

;; EMIR compliance for derivatives
(compliance.verify
  :entity-id "fund-quantum-capital-sicav"
  :framework "EMIR"
  :check-type "DERIVATIVE_COUNTERPARTY"
  :verified-at "2024-11-10T13:30:00Z"
  :compliance-outcome "COMPLIANT"
  :classification "NON_FINANCIAL_COUNTERPARTY_PLUS"
  :requirements-met ["CLEARING_THRESHOLD" "RISK_MITIGATION" "REPORTING"])

;; AIFMD compliance check
(compliance.verify
  :entity-id "quantum-asset-mgmt-sa"
  :framework "AIFMD"
  :check-type "MANAGEMENT_COMPANY"
  :verified-at "2024-11-10T14:00:00Z"
  :compliance-outcome "COMPLIANT"
  :requirements-met ["AUTHORIZATION" "CAPITAL_REQUIREMENTS" "CONDUCT_RULES"])

;; US tax compliance (FATCA)
(compliance.fatca_check
  :entity-id "fund-quantum-capital-sicav"
  :check-date "2024-11-10"
  :fatca-status "PARTICIPATING_FFI"
  :giin "ABC123.12345.MF.442"
  :classification "INVESTMENT_ENTITY"
  :us-reportable-accounts 0
  :compliance-status "CURRENT")

;; CRS compliance
(compliance.crs_check
  :entity-id "fund-quantum-capital-sicav"
  :check-date "2024-11-10"
  :reporting-jurisdictions ["US" "UK" "DE" "FR" "NL" "SG"]
  :crs-classification "INVESTMENT_ENTITY"
  :controlling-persons-identified true
  :reporting-status "CURRENT")

;; Enhanced AML assessment
(compliance.aml_check
  :entity-id "fund-quantum-capital-sicav"
  :check-date "2024-11-10"
  :aml-risk-rating "MEDIUM_HIGH"
  :risk-factors ["COMPLEX_STRUCTURE" "DERIVATIVE_TRADING" "GLOBAL_EXPOSURE" "HIGH_AUM"]
  :mitigating-factors ["REGULATED_FUND" "CSSF_OVERSIGHT" "INSTITUTIONAL_INVESTORS" "ESTABLISHED_TRACK_RECORD"]
  :enhanced-measures ["QUARTERLY_REVIEW" "TRANSACTION_MONITORING" "BENEFICIAL_OWNERSHIP_TRACKING"]
  :ongoing-monitoring-frequency "MONTHLY")

;; ============================================================================
;; PHASE 6: UBO ANALYSIS FOR COMPLEX STRUCTURE
;; ============================================================================

;; UBO calculation for fund structure
(ubo.calc
  :target "fund-quantum-capital-sicav"
  :threshold 25.0
  :calculation-date "2024-11-10"
  :methodology "FUND_SPECIFIC_ANALYSIS"
  :prongs ["OWNERSHIP" "CONTROL" "BENEFICIARY_INTEREST"])

;; UBO outcome for regulated fund
(ubo.outcome
  :target "fund-quantum-capital-sicav"
  :at "2024-11-10T15:00:00Z"
  :threshold 25.0
  :entity-type "REGULATED_COLLECTIVE_INVESTMENT_SCHEME"
  :ubo-determination "FUND_MANAGER_APPROACH"
  :natural-person-ubos [{
    :entity "person-dr-elena-kowalski"
    :entity-type "NATURAL_PERSON"
    :ubo-basis "SENIOR_MANAGING_OFFICIAL"
    :control-mechanism "PORTFOLIO_MANAGEMENT_CONTROL"
    :evidence ["doc-elena-regulatory-approval-001" "doc-appointment-letter-elena-001"]
    :ubo-status "SENIOR_MANAGING_OFFICIAL"
  } {
    :entity "person-michael-brennan"
    :entity-type "NATURAL_PERSON"
    :ubo-basis "SENIOR_MANAGING_OFFICIAL"
    :control-mechanism "EXECUTIVE_MANAGEMENT_CONTROL"
    :evidence ["doc-michael-regulatory-approval-001" "doc-appointment-letter-michael-001"]
    :ubo-status "SENIOR_MANAGING_OFFICIAL"
  }]
  :regulatory-notes "As a UCITS fund, UBO identification follows senior managing official approach per 4AMLD Article 3(6)(b)"
  :investigation-complete true)

;; Role assignments based on fund structure analysis
(role.assign
  :entity "person-dr-elena-kowalski"
  :role "SeniorManagingOfficial"
  :entity-context "fund-quantum-capital-sicav"
  :role-basis "PORTFOLIO_MANAGEMENT_AUTHORITY"
  :regulatory-framework "4AMLD"
  :assigned-date "2024-11-10T15:00:00Z")

(role.assign
  :entity "person-michael-brennan"
  :role "SeniorManagingOfficial"
  :entity-context "fund-quantum-capital-sicav"
  :role-basis "EXECUTIVE_MANAGEMENT_AUTHORITY"
  :regulatory-framework "4AMLD"
  :assigned-date "2024-11-10T15:00:00Z")

;; ============================================================================
;; PHASE 7: PRIME BROKERAGE CASE MANAGEMENT
;; ============================================================================

;; Create comprehensive onboarding case
(case.create
  :case-id "CASE-QUANTUM-ONBOARDING-001"
  :case-type "INSTITUTIONAL_PRIME_BROKERAGE"
  :client-entity "fund-quantum-capital-sicav"
  :case-priority "HIGH"
  :complexity-level "COMPLEX"
  :created-date "2024-11-10"
  :assigned-team "prime-brokerage-emea"
  :relationship-manager "senior-rm-luxembourg"
  :target-completion "2024-12-15"
  :regulatory-requirements ["MIFID_II" "EMIR" "AIFMD" "CSSF_CDD"]
  :services-requested ["CUSTODY" "PRIME_BROKERAGE" "DERIVATIVE_TRADING" "SECURITIES_LENDING" "REPO_FINANCING"])

;; Progress update after KYC completion
(case.update
  :case-id "CASE-QUANTUM-ONBOARDING-001"
  :update-date "2024-11-15"
  :status "KYC_UBO_COMPLETE"
  :progress-percent 40
  :completed-stages ["INITIAL_DOCUMENTATION" "KYC_VERIFICATION" "UBO_ANALYSIS" "COMPLIANCE_CLEARANCE"]
  :current-stage "ISDA_DOCUMENTATION"
  :next-stages ["PRIME_BROKERAGE_AGREEMENT" "ACCOUNT_OPENING" "SYSTEM_INTEGRATION"]
  :risk-assessment "MEDIUM_HIGH"
  :notes "Enhanced KYC completed for UCITS fund. Complex structure analysis complete. UBO identified per senior managing official approach. Ready for ISDA documentation.")

;; ============================================================================
;; PHASE 8: COMPREHENSIVE ISDA DOCUMENTATION
;; ============================================================================

;; Catalog ISDA Master Agreement
(document.catalog
  :document-id "doc-isda-master-quantum-001"
  :document-type "ISDA_MASTER_AGREEMENT"
  :issuer "isda_inc"
  :title "ISDA Master Agreement - Quantum Capital SICAV / Prime Broker"
  :parties ["fund-quantum-capital-sicav" "prime-broker-london-entity"]
  :document-date "2024-11-20"
  :jurisdiction "EN"
  :language "EN"
  :confidentiality-level "RESTRICTED"
  :extracted-data {
    :isda.governing_law "EN"
    :isda.master_agreement_version "2002"
    :isda.multicurrency_cross_default true
    :isda.cross_default_threshold 50000000
    :isda.termination_currency "EUR"
    :isda.credit_support_annex true
    :isda.additional_termination_events ["FUND_INSOLVENCY" "REGULATORY_ACTION" "NAV_DECLINE"]
  })

;; Establish ISDA Master Agreement
(isda.establish_master
  :agreement-id "ISDA-QUANTUM-PRIME-001"
  :party-a "fund-quantum-capital-sicav"
  :party-b "prime-broker-london-entity"
  :version "2002"
  :governing-law "EN"
  :agreement-date "2024-11-20"
  :effective-date "2024-11-25"
  :multicurrency true
  :cross-default true
  :cross-default-threshold 50000000
  :termination-currency "EUR"
  :additional-representations ["FUND_REPRESENTATIONS" "UCITS_COMPLIANCE"]
  :document-id "doc-isda-master-quantum-001")

;; Enhanced Credit Support Annex for fund
(document.catalog
  :document-id "doc-csa-quantum-001"
  :document-type "CREDIT_SUPPORT_ANNEX"
  :issuer "clifford_chance_london"
  :title "Credit Support Annex - Multi-Currency VM/IM"
  :parties ["fund-quantum-capital-sicav" "prime-broker-london-entity"]
  :document-date "2024-11-20"
  :jurisdiction "EN"
  :confidentiality-level "RESTRICTED"
  :extracted-data {
    :isda.csa_base_currency "EUR"
    :isda.threshold_party_a 25000000
    :isda.threshold_party_b 0
    :isda.minimum_transfer_amount 1000000
    :isda.eligible_collateral ["cash_eur" "cash_usd" "cash_gbp" "german_bunds" "us_treasury" "uk_gilts"]
    :isda.margin_approach "VM_IM"
    :isda.initial_margin_model "ISDA_SIMM"
  })

(isda.establish_csa
  :csa-id "CSA-QUANTUM-PRIME-001"
  :master-agreement-id "ISDA-QUANTUM-PRIME-001"
  :base-currency "EUR"
  :threshold-party-a 25000000
  :threshold-party-b 0
  :minimum-transfer 1000000
  :rounding-amount 100000
  :eligible-collateral ["cash_eur" "cash_usd" "cash_gbp" "german_bunds" "us_treasury" "uk_gilts"]
  :valuation-percentage {
    "cash_eur" 100
    "cash_usd" 100
    "cash_gbp" 100
    "german_bunds" 95
    "us_treasury" 98
    "uk_gilts" 96
  }
  :margin-approach "VM_IM"
  :initial-margin-model "ISDA_SIMM"
  :dispute-resolution "LONDON_ARBITRATION"
  :effective-date "2024-11-25"
  :document-id "doc-csa-quantum-001")

;; ============================================================================
;; PHASE 9: SOPHISTICATED DERIVATIVE TRADING PROGRAM
;; ============================================================================

;; Execute EUR/USD equity swap for European exposure
(isda.execute_trade
  :trade-id "TRADE-EQUITY-SWAP-EU-001"
  :master-agreement-id "ISDA-QUANTUM-PRIME-001"
  :product-type "EQUITY_SWAP"
  :trade-date "2024-12-02"
  :effective-date "2024-12-04"
  :termination-date "2025-06-04"
  :notional-amount 75000000
  :currency "EUR"
  :payer "fund-quantum-capital-sicav"
  :receiver "prime-broker-london-entity"
  :underlying "EURO_STOXX_50"
  :calculation-agent "prime-broker-london-entity"
  :settlement-terms {
    :return-type "TOTAL_RETURN"
    :funding-spread 0.0125
    :reset-frequency "MONTHLY"
    :payment-frequency "MONTHLY"
    :dividend-treatment "PASS_THROUGH"
  })

;; Execute USD interest rate swap for duration hedging
(isda.execute_trade
  :trade-id "TRADE-USD-IRS-HEDGE-001"
  :master-agreement-id "ISDA-QUANTUM-PRIME-001"
  :product-type "IRS"
  :trade-date "2024-12-03"
  :effective-date "2024-12-05"
  :termination-date "2029-12-05"
  :notional-amount 100000000
  :currency "USD"
  :payer "prime-broker-london-entity"
  :receiver "fund-quantum-capital-sicav"
  :underlying "USD-SOFR"
  :calculation-agent "prime-broker-london-entity"
  :settlement-terms {
    :payment-frequency "QUARTERLY"
    :day-count-convention "ACT/360"
    :business-day-convention "MODIFIED_FOLLOWING"
    :reset-frequency "QUARTERLY"
    :fixed-rate 0.0475
  })

;; Execute credit default swap for credit exposure
(isda.execute_trade
  :trade-id "TRADE-CDS-PROTECTION-001"
  :master-agreement-id "ISDA-QUANTUM-PRIME-001"
  :product-type "CDS"
  :trade-date "2024-12-04"
  :effective-date "2024-12-09"
  :termination-date "2029-12-20"
  :notional-amount 50000000
  :currency "EUR"
  :payer "fund-quantum-capital-sicav"
  :receiver "prime-broker-london-entity"
  :underlying "iTraxx_Europe_Main"
  :calculation-agent "prime-broker-london-entity"
  :settlement-terms {
    :premium-rate 0.0095
    :payment-frequency "QUARTERLY"
    :recovery-rate 0.40
    :auction-settlement true
  })

;; Document comprehensive trade confirmations
(document.catalog
  :document-id "doc-confirmation-equity-swap-001"
  :document-type "TRADE_CONFIRMATION"
  :issuer "prime_broker_london_entity"
  :title "Equity Swap Confirmation - Euro Stoxx 50 Total Return"
  :parties ["fund-quantum-capital-sicav" "prime-broker-london-entity"]
  :document-date "2024-12-02"
  :confidentiality-level "CONFIDENTIAL"
  :extracted-data {
    :isda.trade_id "TRADE-EQUITY-SWAP-EU-001"
    :isda.product_type "EQUITY_SWAP"
    :isda.notional_amount 75000000
    :isda.currency "EUR"
    :isda.underlying_index "EURO_STOXX_50"
    :isda.return_type "TOTAL_RETURN"
    :isda.funding_spread 0.0125
  })

;; ============================================================================
;; PHASE 10: PORTFOLIO VALUATION & RISK MANAGEMENT
;; ============================================================================

;; Comprehensive portfolio valuation
(isda.value_portfolio
  :valuation-id "VAL-QUANTUM-20241210"
  :portfolio-id "PORTFOLIO-QUANTUM-PRIME"
  :valuation-date "2024-12-10"
  :valuation-agent "prime-broker-london-entity"
  :methodology "MARKET_STANDARD_FUND"
  :base-currency "EUR"
  :trades-valued ["TRADE-EQUITY-SWAP-EU-001" "TRADE-USD-IRS-HEDGE-001" "TRADE-CDS-PROTECTION-001"]
  :gross-mtm 15750000
  :net-mtm 15750000
  :market-data-sources ["Bloomberg" "Refinitiv" "Markit"]
  :calculation-details {
    :fx-rates {"USD/EUR" 0.9250, "GBP/EUR" 1.1950}
    :equity-indices {"EURO_STOXX_50" 4850.25, "S&P_500" 4725.80}
    :ir-curves {"EUR-EURIBOR" "curve_20241210", "USD-SOFR" "curve_20241210"}
    :credit-spreads {"iTraxx_Europe_Main" 95.5}
    :volatility-surfaces "complete_set_20241210"
  })

;; Initial margin calculation using ISDA SIMM
(isda.margin_call
  :call-id "MC-IM-QUANTUM-20241210"
  :csa-id "CSA-QUANTUM-PRIME-001"
  :call-date "2024-12-10"
  :valuation-date "2024-12-10"
  :margin-type "INITIAL_MARGIN"
  :calling-party "prime-broker-london-entity"
  :called-party "fund-quantum-capital-sicav"
  :simm-calculation {
    :delta-sensitivity 8500000
    :vega-sensitivity 2100000
    :curvature-sensitivity 1200000
    :base-correlation-sensitivity 450000
  }
  :im-amount 12500000
  :currency "EUR"
  :deadline "2024-12-11T17:00:00Z"
  :calculation-details {
    :model "ISDA_SIMM_V2_6"
    :risk-factors ["IR" "FX" "EQ" "CRQ"]
    :diversification-benefit 3200000
    :regulatory-multiplier 1.0
  })

;; Post initial margin collateral
(isda.post_collateral
  :posting-id "POST-IM-QUANTUM-20241211"
  :call-id "MC-IM-QUANTUM-20241210"
  :posting-party "fund-quantum-capital-sicav"
  :receiving-party "prime-broker-london-entity"
  :collateral-type "cash_eur"
  :amount 12500000
  :currency "EUR"
  :posting-date "2024-12-11"
  :settlement-date "2024-12-11"
  :custodian "state-street-london"
  :valuation 12500000
  :margin-type "INITIAL_MARGIN")

;; ============================================================================
;; PHASE 11: REGULATORY REPORTING & COMPLIANCE
;; ============================================================================

;; EMIR trade reporting
(document.query
  :query-id "QUERY-EMIR-QUANTUM-001"
  :query-type "REGULATORY_REPORTING"
  :search-criteria {
    :document-types ["TRADE_CONFIRMATION" "ISDA_MASTER_AGREEMENT"]
    :parties ["fund-quantum-capital-sicav"]
    :date-range ["2024-12-01" "2024-12-31"]
    :jurisdictions ["EN" "LU"]
    :regulatory-frameworks ["EMIR"]
    :product-types ["EQUITY_SWAP" "IRS" "CDS"]
  }
  :output-format "EMIR_XML"
  :regulatory-framework "EMIR"
  :reporting-entity "fund-quantum-capital-sicav"
  :reporting-date "2024-12-31")

;; MiFID II transaction reporting
(compliance.generate_report
  :report-id "MIFID-TRANSACTION-QUANTUM-Q4-2024"
  :entity-id "fund-quantum-capital-sicav"
  :report-type "MIFID_TRANSACTION_REPORTING"
  :reporting-period ["2024-10-01" "2024-12-31"]
  :frameworks ["MIFID_II"]
  :report-date "2024-12-31"
  :includes {
    :derivative-transactions ["TRADE-EQUITY-SWAP-EU-001" "TRADE-USD-IRS-HEDGE-001" "TRADE-CDS-PROTECTION-001"]
    :client-classification "PROFESSIONAL_CLIENT"
    :execution-venue "OTC"
    :best-execution-compliance true
    :product-governance-compliance true
  })

;; AIFMD reporting for management company
(compliance.generate_report
  :report-id "AIFMD-QUANTUM-MGMT-2024"
  :entity-id "quantum-asset-mgmt-sa"
  :report-type "AIFMD_REPORTING"
  :reporting-period ["2024-01-01" "2024-12-31"]
  :frameworks ["AIFMD"]
  :report-date "2024-12-31"
  :includes {
    :aum-managed 4200000000
    :funds-managed ["fund-quantum-capital-sicav"]
    :leverage-information {
      :gross-method 180.5
      :commitment-method 145.2
    }
    :systemic-risk-assessment "NON_SYSTEMIC"
    :liquidity-management "ADEQUATE"
  })

;; ============================================================================
;; PHASE 12: ONGOING MONITORING & CASE COMPLETION
;; ============================================================================

;; Final case update
(case.update
  :case-id "CASE-QUANTUM-ONBOARDING-001"
  :update-date "2024-12-15"
  :status "ONBOARDING_COMPLETE"
  :progress-percent 100
  :completed-stages ["INITIAL_DOCUMENTATION" "KYC_VERIFICATION" "UBO_ANALYSIS"
                     "COMPLIANCE_CLEARANCE" "ISDA_DOCUMENTATION" "PRIME_BROKERAGE_AGREEMENT"
                     "ACCOUNT_OPENING" "SYSTEM_INTEGRATION" "INITIAL_TRADING"]
  :completion-date "2024-12-15T16:00:00Z"
  :risk-assessment "MEDIUM_HIGH"
  :ongoing-requirements ["MONTHLY_PORTFOLIO_REVIEW" "QUARTERLY_KYC_REFRESH" "ANNUAL_UBO_REVIEW" "EMIR_REPORTING"]
  :notes "Successfully onboarded sophisticated UCITS fund with comprehensive prime brokerage services. ISDA documentation complete. Derivative trading program operational. All regulatory requirements satisfied.")

;; Case closure
(case.close
  :case-id "CASE-QUANTUM-ONBOARDING-001"
  :closed-date "2024-12-15T16:00:00Z"
  :closure-reason "SUCCESSFUL_COMPLETION"
  :final-outcome "PRIME_BROKERAGE_CLIENT_ACTIVE"
  :handover-team "prime-brokerage-coverage-emea"
  :relationship-manager "senior-rm-institutional-funds"
  :credit-limit-approved 500000000
  :services-activated ["CUSTODY" "DERIVATIVE_TRADING" "SECURITIES_LENDING" "REPO_FINANCING"]
  :ongoing-requirements ["MONTHLY_RISK_REVIEW" "QUARTERLY_COMPLIANCE_ASSESSMENT" "ANNUAL_RELATIONSHIP_REVIEW"])

;; Document comprehensive usage tracking
(document.use
  :document-id "doc-quantum-cssf-auth-001"
  :used-by-process "PRIME_BROKERAGE_ONBOARDING"
  :usage-date "2024-11-10"
  :usage-context "Regulatory authorization verification for fund onboarding"
  :business-purpose "REGULATORY_COMPLIANCE"
  :workflow-reference "CASE-QUANTUM-ONBOARDING-001")

(document.use
  :document-id "doc-isda-master-quantum-001"
  :used-by-process "DERIVATIVE_TRADING_AUTHORIZATION"
  :usage-date "2024-12-02"
  :usage-context "Legal framework establishment for derivative transactions"
  :business-purpose "TRADING_AUTHORIZATION"
  :workflow-reference "CASE-QUANTUM-ONBOARDING-001")

;; ============================================================================
;; COMPREHENSIVE WORKFLOW SUMMARY
;; ============================================================================

;; This sophisticated hedge fund onboarding workflow demonstrates:
;;
;; 1. Complex Entity Structure Management:
;;    - UCITS fund with management company structure
;;    - Multi-jurisdiction regulatory oversight (LU, EU)
;;    - Institutional investor base with diverse geographies
;;    - Senior managing official approach for UBO identification
;;
;; 2. Enhanced Regulatory Compliance:
;;    - CSSF authorization verification and ongoing compliance
;;    - MiFID II professional client classification
;;    - EMIR derivative counterparty assessment
;;    - AIFMD management company compliance
;;    - Multi-jurisdiction tax compliance (FATCA, CRS)
;;    - Enhanced AML assessment with sophisticated risk factors
;;
;; 3. Sophisticated Document Management:
;;    - Comprehensive fund documentation cataloging
;;    - AI-powered financial analysis and risk extraction
;;    - Cross-jurisdictional document verification
;;    - Complete audit trail with evidence tracking
;;
;; 4. Advanced ISDA Implementation:
;;    - Complex Master Agreement with fund-specific terms
;;    - Enhanced CSA with Initial Margin (ISDA SIMM)
;;    - Multi-asset class derivative trading program
;;    - Sophisticated risk management and collateral posting
;;
;; 5. Institutional Prime Brokerage Services:
;;    - High-value credit facilities and risk limits
;;    - Multi-currency and multi-asset class support
;;    - Advanced portfolio valuation and risk analytics
;;    - Comprehensive regulatory reporting automation
;;
;; 6. End-to-End Process Integration:
;;    - Seamless workflow from initial documentation to active trading
;;    - Cross-domain data consistency and audit trails
;;    - Regulatory compliance automation and monitoring
;;    - Ongoing relationship management and risk monitoring
;;
;; Key Technical Achievements:
;; - Multi-domain DSL integration across 6 business domains
;; - AttributeID-typed data consistency throughout workflow
;; - AI-powered document processing and risk assessment
;; - Comprehensive regulatory compliance automation
;; - Sophisticated derivative workflow management
;; - Complete audit trail and evidence management
;;
;; This workflow represents the pinnacle of institutional client
;; onboarding complexity, demonstrating the full power of the
;; DSL-as-State architecture with multi-domain integration.
